Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03120481
What this trial is testing

Controls for Respiratory Diseases

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAsthmaIdiopathic Pulmonary Fibrosis+3 more
Seoul National University Hospital 1,572
Early research (Phase 1)Ended earlyNCT05644600
What this trial is testing

Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Who this might be right for
Healthy Subjects
AstraZeneca 18
Large-scale testing (Phase 3)Ended earlyNCT03711162
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 525
Not applicableStudy completedNCT01462006
What this trial is testing

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisDiffuse Parenchymal Lung DiseaseInterstitial Lung Disease
University of Virginia 32
Early research (Phase 1)Study completedNCT04233814
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Rein Therapeutics 71
Post-approval studies (Phase 4)UnknownNCT00637065
What this trial is testing

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more
Royal Brompton & Harefield NHS Foundation Trust 48
Large-scale testing (Phase 3)Study completedNCT01335464
What this trial is testing

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 515
Not applicableStudy completedNCT03211507
What this trial is testing

Idiopathic Pulmonary Fibrosis Job Exposures Study

Who this might be right for
IPFIdiopathic Pulmonary Fibrosis
Imperial College London 960
Not applicableStudy completedNCT06372353
What this trial is testing

The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis, Idiopathic
Marmara University 28
Large-scale testing (Phase 3)Study completedNCT00391443
What this trial is testing

BUILD 3: Bosentan Use in Interstitial Lung Disease

Who this might be right for
Idiopathic Pulmonary Fibrosis
Actelion 616
Testing effectiveness (Phase 2)Study completedNCT01872689
What this trial is testing

Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 505
Early research (Phase 1)Ended earlyNCT04589260
What this trial is testing

TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Theravance Biopharma 72
Testing effectiveness (Phase 2)Study completedNCT02036580
What this trial is testing

D2212C00002 J-Phase II Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
AstraZeneca 37
Early research (Phase 1)Study completedNCT05383131
What this trial is testing

To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 33
Large-scale testing (Phase 3)Looking for participantsNCT07299695
What this trial is testing

Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisAcute Exacerbation of Idiopathic Pulmonary Fibrosis
Argyrios Tzouvelekis 196
Not applicableStudy completedNCT07169253
What this trial is testing

Prognostic Score Comparison in IPF and HP

Who this might be right for
IPFFibrotic Lung DiseaseHypersensitivity Pneumonitis+1 more
Saglik Bilimleri Universitesi 143
Testing effectiveness (Phase 2)WithdrawnNCT02168530
What this trial is testing

Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche
Not applicableWithdrawnNCT02187393
What this trial is testing

Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHealthy
University of Colorado, Denver
Not applicableNot Yet RecruitingNCT07613216
What this trial is testing

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Sarcoidosis LungPulmonary Hypertension+1 more
Cosmos Rx, Inc 100
Testing effectiveness (Phase 2)Ended earlyNCT02989168
What this trial is testing

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Global Blood Therapeutics 14
Next Page